WEC
50
4
EQIX
58
-9
LYB
36
-3
SHW
56
-2
TSCO
49
4
AON
43
7
OXY
42
2
HOG
34
4
DIS
48
3
XRAY
31
2
ZION
57
4
EXPE
26
-6
PNW
66
3
NTAP
43
6
ROST
70
3
BWA
75
-7
ETN
69
-2
KHC
18
3
MCO
42
5
SCHW
43
-2
WEC
50
4
EQIX
58
-9
LYB
36
-3
SHW
56
-2
TSCO
49
4
AON
43
7
OXY
42
2
HOG
34
4
DIS
48
3
XRAY
31
2
ZION
57
4
EXPE
26
-6
PNW
66
3
NTAP
43
6
ROST
70
3
BWA
75
-7
ETN
69
-2
KHC
18
3
MCO
42
5
SCHW
43
-2
Financhill
Back

Bristol Myers Squibb Co. 10K Form

Buy
64

BMY
Bristol Myers Squibb Co.

Last Price:
$60.73
Seasonality Move:
2.01%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BMY News And Ratings

See the #1 stock for the next 7 days that we like better than BMY

BMY Financial Statistics

Sales & Book Value

Annual Sales: $48.2B
Cash Flow: $1.6B
Price / Cash Flow: 9.64
Annual Sales: $9.07
Price / Book: 6.7

Profitability

EPS (TTM): 3.45870
Net Income (TTM): $7.1B
Gross Margin: $31.8B
Return on Equity: 39.9%
Return on Assets: 7.56%

Bristol Myers Squibb Co. Earnings Forecast

Key Bristol Myers Squibb Co. Financial Ratios

  • The Gross Profit Margin over the past 46 years for BMY is 65.90%.
  • The Selling, General & Administrative Expenses for BMY have been equal to 15.08% of Gross Profit Margin.
  • The Research & Development expenses have been 19.70% of Revenue.
  • The Interest Expense is 26.80% of Operating Income.
  • The Net Earning history of BMY is 14.64% of Total Revenues.
  • Per Share Earnings over the last 46 years have been positive in 21 years.

Bristol Myers Squibb Co. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: S&P500
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: BMY
CUSIP: 110122
Website: bms.com

Debt

Debt-to-Equity Ratio: 2.55
Current Ratio: 1.26
Quick Ratio: 0.88

Price-to-Earnings

Trailing P/E Ratio: 17.56
Forward P/E Ratio: 10.08

BMY Technical Analysis vs Fundamental Analysis

Buy
64
Bristol Myers Squibb Co. (BMY) is a Buy

Is Bristol Myers Squibb Co. a Buy or a Sell?